Janneke W Duijster (J W Duijster, Janneke Duijster)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Listeria Monocytogenes

Antimicrobial Resistance

Cross Sectional

Breast Cancer Risk

Top Venues

Expert opinion on drug safety

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

C Ouaddouh, Janneke W Duijster, T Lieber, Florence P A M van Hunsel
The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands. Expert opinion on drug safety (2023)
Janneke W Duijster, M E Schoep, T E Nieboer, R Jajou, Agnes C Kant, F Van Hunsel
Menstrual abnormalities after COVID-19 vaccination in the Netherlands: a description of spontaneous and longitudinal patient-reported data. British journal of clinical pharmacology (2023)
P Slingerland, Florence P A M van Hunsel, T Lieber, Leontine van Balveren, Janneke W Duijster
The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands. Drug safety (2023)
Janneke W Duijster, Jørgen V Hansen, Eelco Franz, Jacques J C Neefjes, Morten Frisch, Lapo Mughini-Gras, Steen Ethelberg
Association between Salmonella infection and colon cancer: a nationwide registry-based cohort study. Epidemiology and infection 149 (2021)
Janneke W Duijster, Lapo Mughini-Gras, Jacques Neefjes, Eelco Franz
Occupational exposure and risk of colon cancer: a nationwide registry study with emphasis on occupational exposure to zoonotic gastrointestinal pathogens. BMJ open 11 (8) (2021)